Merger Law for Biotech and Killer Acquisitions
10 Pages Posted: 31 Aug 2020 Last revised: 15 Dec 2020
Date Written: September 17, 2020
This Essay suggests a framework of how to conceptualize “killer acquisitions” in the biotech sector. In a killer acquisition, a larger branded pharmaceutical company buys a start-up company with a pipeline product with the intention to shut the pipeline product down. The Essay offers a way to police against acquisitions that may hurt consumers and still encourage pro-competitive acquisitions that may improve innovation and consumer welfare.
Keywords: pharma, antitrust, mergers, killer acquisitions, innovation, drug development
JEL Classification: O31, L41, G34, L65
Suggested Citation: Suggested Citation